Results 181 to 190 of about 30,536 (239)

Multi-Organ Adverse Reaction to Two Hypomethylating Agents: A Challenge in High-Risk Myelodysplastic Syndrome Treatment. [PDF]

Hematol Rep
Alves SB, Pierdomenico F.
europepmc   +1 more source

CDADC1 is a vertebrate-specific dCTP deaminase that metabolizes gemcitabine and decitabine to prevent cellular toxicity. [PDF]

Proc Natl Acad Sci U S A
Rodriguez MM, Chatterjee D, Guerry J, Patenaude AM, Cohen CCH, Bois T, Larouche A, Ferreira SR, Bertomeu T, Chatr-Aryamontri A, Zhang L, Mader S, Nislow C, St-Jean G, Guindon Y, Zahn A, Di Noia JM.   +16 more
europepmc   +1 more source

Genome-wide DNA methylation analysis identifies kidney epigenetic dysregulation in a cystinosis mouse model. [PDF]

Front Cell Dev Biol
Rossi MN, Ciolfi A, Matteo V, Pedace L, Nardini C, Loricchio E, Caiello I, Bellomo F, Taranta A, De Leo E, Tartaglia M, Emma F, De Benedetti F, Miele E, Prencipe G.   +14 more
europepmc   +1 more source

The role of macrophages in the mitigation by decitabine of acute allograft rejection. [PDF]

Front Transplant
Daccarett-Bojanini WN, Sollmann M, Yarnoff KM, Heller NM, Dodd-O JM.   +4 more
europepmc   +1 more source

Potential Off-Target Effect of Gilteritinib With Venetoclax Decreases Tumor Burden for Patients With Relapsed/Refractory Wild-Type <i>FLT3</i> Acute Myeloid Leukemia/Myelodysplastic Neoplasms. [PDF]

Case Rep Hematol
Chang S, Pan Z, Zhang Y, Zhang Y, Sun J, Guo Y, Guo X, Guo Z.   +7 more
europepmc   +1 more source

Hypomethylating agents alone or in combination with venetoclax in very elderly acute myeloid leukemia patients: less treatment, better care? [PDF]

Ann Hematol
Tarantini F, Contento C, Vigna E, Carluccio V, Greco G, Pasciolla C, Ciuffreda L, Rossi G, Urbano MA, D'Ambrosio A, Aprile L, Gagliardi VP, Delia M, Attolico I, Carluccio P, Federico V, Bruzzese A, Di Renzo N, Gentile M, Tarantini G, Mele A, Guarini A, Melillo LMA, Carella AM, Pastore D, Frigeri F, Maggi A, Cumbo C, Specchia G, Musto P, Albano F.   +30 more
europepmc   +1 more source

Hypermethylation of DNA impairs megakaryogenesis in delayed platelet recovery after allogeneic hematopoietic stem cell transplantation. [PDF]

Sci Adv
Tang Y, Song X, Zhang Z, Yao Y, Pan T, Qi J, Xia L, Wu D, Han Y.   +8 more
europepmc   +1 more source

DNA demethylating agents suppress preclinical models of synovial sarcoma. [PDF]

J Clin Invest
Hasegawa N, Benabdallah NS, Smith-Fry K, Li L, McCollum S, Li J, Jones CA, Wagner L, Dalal V, Golde V, Pejkovska A, Carroll L, Haldar M, Pollack SM, Lowe SW, Nielsen TO, Banito A, Jones KB.   +17 more
europepmc   +1 more source

The role of DNA methylation and demethylation in bladder cancer: a focus on therapeutic strategies. [PDF]

Front Oncol
Strasenburg W, Borowczak J, Piątkowska D, Jóźwicki J, Grzanka D.   +4 more
europepmc   +1 more source

A Phase 1b/2 Study of TP-0903 and Decitabine Targeting Mutant TP53 and/or Complex Karyotype in Patients with Untreated Acute Myeloid Leukemia ≥Age 60 Years. [PDF]

Cancer Res Commun
Eisenmann ED, Swords R, Huang Y, Orwick S, Buelow D, Abbott N, Phelps M, Zeidner J, Foster MC, Lin TL, Baer MR, Madanat YF, Kovacsovics T, Redner R, Al-Mansour Z, Bhatnagar B, Stefanos M, Martycz M, Druggan F, Chen TL, Yocum AO, Borate U, Druker BJ, Burd A, Levine RL, Byrd JC, Baker SD, Mims AS.   +27 more
europepmc   +1 more source